Bayer A.G.Bayer A.G.Bayer A.G.

Bayer A.G.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪20.37 B‬USD
−0.26USD
‪−3.18 B‬USD
‪51.50 B‬USD
‪3.93 B‬
Beta (1Y)
0.16

About BAYER AG NA O.N.


CEO
William N. Anderson
Headquarters
Leverkusen
Website
Founded
1952
FIGI
BBG000BYMB76
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
M
BAYZ4140707
Monsanto Company 4.4% 15-JUL-2044
Yield to maturity
8.53%
Maturity date
Jul 15, 2044
M
BAYZ4140706
Monsanto Company 4.7% 15-JUL-2064
Yield to maturity
8.03%
Maturity date
Jul 15, 2064
M
BAYZ3875861
Monsanto Company 3.6% 15-JUL-2042
Yield to maturity
7.93%
Maturity date
Jul 15, 2042
B
US7274NBG7
BAY.US FI.II. 2045 144A
Yield to maturity
7.73%
Maturity date
Apr 15, 2045
B
US7274NBH5
BAY.US FI.II. 2064 144A
Yield to maturity
7.69%
Maturity date
Jul 15, 2064
B
BAYZ4685470
Bayer US Finance II LLC 3.95% 15-APR-2045
Yield to maturity
7.66%
Maturity date
Apr 15, 2045
B
BAYZ4804053
Bayer US Finance II LLC 3.6% 15-JUL-2042
Yield to maturity
7.56%
Maturity date
Jul 15, 2042
B
BAYZ4662675
Bayer US Finance II LLC 4.4% 15-JUL-2044
Yield to maturity
7.51%
Maturity date
Jul 15, 2044
M
BAYZ4230946
Monsanto Company 3.95% 15-APR-2045
Yield to maturity
7.51%
Maturity date
Apr 15, 2045
B
US7274NBF9
BAY.US FI.II. 2044 144A
Yield to maturity
7.47%
Maturity date
Jul 15, 2044
B
USU07265AH1
BAY.US FI.II. 18/48 REGS
Yield to maturity
7.39%
Maturity date
Jun 25, 2048

Explore more bonds 

Curated watchlists where BAYRY is featured.